Skip to main content
Orchid Pharma Limited logo

Orchid Pharma Limited — Investor Relations & Filings

Ticker · ORCHPHARMA ISIN · INE191A01027 LEI · 33580076KIKCYSLZVF05 BSE.NS Manufacturing
Open in API
Filings indexed 451 across all filing types
Latest filing 2021-07-15 Regulatory Filings
Country IN India
Listing BSE.NS ORCHPHARMA

About Orchid Pharma Limited

https://www.orchidpharma.com/

Orchid Pharma Limited is a vertically integrated organization focused on the development, manufacture, and marketing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). The company specializes in the anti-infectives segment, with a particular emphasis on cephalosporins and penicillins. Its operations span the entire value chain, including advanced research and development, process chemistry, and large-scale manufacturing. Orchid Pharma maintains facilities that adhere to rigorous international regulatory standards, enabling the supply of high-quality generic formulations and complex molecules to global markets. The company prioritizes innovation in chemical synthesis and formulation development to address complex therapeutic requirements and enhance healthcare outcomes through a robust portfolio of essential medicines.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings Classification · 100% confidence The document text contains only placeholders for omitted pictures and no substantive text or financial data. The true document length is only 115 characters, indicating it is extremely short and does not contain any report content. There is no indication of any report, announcement, or filing type. Given the lack of content, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category for miscellaneous filings without substantive information.
2021-07-15 English
Board Meeting — Fund Raising
Regulatory Filings Classification · 90% confidence The document text is extremely short (645 characters) and consists mainly of address and listing information for stock exchanges (NSE, BSE, Luxembourg, London). There is no substantive financial data, report content, or detailed announcement. It appears to be a brief regulatory or listing-related notice without any report or financial results. Given the lack of any report or announcement content, and the short length, this fits best as a Regulatory Filing (RNS) which is a fallback category for miscellaneous filings that do not fit other categories.
2021-07-12 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2021-07-05 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document text is extremely short (142 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report title, no regulatory references, and no indication of any report or announcement. Given the lack of content, the document cannot be classified as a report or detailed filing. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous or non-informative filings.
2021-07-05 English
Updates
Regulatory Filings
2021-07-02 English
Shareholders meeting
Regulatory Filings
2021-07-01 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.